11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      G-quadruplex oligonucleotide AS1411 as a cancer-targeting agent: Uses and mechanisms.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          AS1411 is a 26-mer G-rich DNA oligonucleotide that forms a variety of G-quadruplex structures. It was identified based on its cancer-selective antiproliferative activity and subsequently determined to be an aptamer to nucleolin, a multifunctional protein that preferentially binds quadruplex nucleic acids and which is present at high levels on the surface of cancer cells. AS1411 has exceptionally efficient cellular internalization compared to non-quadruplex DNA sequences.

          Related collections

          Author and article information

          Journal
          Biochim. Biophys. Acta
          Biochimica et biophysica acta
          Elsevier BV
          0006-3002
          0006-3002
          May 2017
          : 1861
          : 5 Pt B
          Affiliations
          [1 ] Department of Medicine, University of Louisville, USA; James Graham Brown Cancer Center, University of Louisville, USA. Electronic address: paula.bates@louisville.edu.
          [2 ] Department of Medicine, University of Arizona, USA.
          [3 ] Department of Medicine, University of Louisville, USA; James Graham Brown Cancer Center, University of Louisville, USA.
          [4 ] Department of Biomedical Engineering, University of Louisville, USA.
          Article
          S0304-4165(16)30509-8
          10.1016/j.bbagen.2016.12.015
          28007579
          e8df881c-fef0-49a9-a86a-1cec47a06ab0
          History

          AS1411,Aptamer,Cancer,Contrast agent,Drug delivery,Imaging,Nanoparticles,Nucleolin,Quadruplex,Radiosensitizer

          Comments

          Comment on this article